federal_register: 2014-19261

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts
2014-19261 Draft Guidance for Industry on Best Practices in Developing Proprietary Names for Drugs; Reopening of the Comment Period Notice The Food and Drug Administration (FDA) is reopening the comment period for the draft guidance entitled "Best Practices in Developing Proprietary Names for Drugs," which published in the Federal Register of May 29, 2014 (79 FR 30852). FDA is reopening the comment period in response to several requests for additional time and to allow interested persons more time to submit comments. 2014-08-14 2014 8 https://www.federalregister.gov/documents/2014/08/14/2014-19261/draft-guidance-for-industry-on-best-practices-in-developing-proprietary-names-for-drugs-reopening-of https://www.govinfo.gov/content/pkg/FR-2014-08-14/pdf/2014-19261.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA) is reopening the comment period for the draft guidance entitled "Best Practices in Developing Proprietary Names for Drugs," which published in the Federal Register of May 29, 2014 (79 FR 30852). FDA is reopening...

Links from other tables